Validation of a quantitative PCR-high-resolution melting protocol for simultaneous screening ofCOL1A1andCOL1A2point mutations and large rearrangements: Application for diagnosis of osteogenesis imperfecta
- 18 July 2012
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 33 (12) , 1697-1707
Abstract
Osteogenesis imperfecta (OI) is a connective tissue disorder mostly characterized by autosomal dominant inheritance. Over 1,100 causal mutations have been identified scattered along all exons of genes encoding type I collagen precursors, COL1A1 and COL1A2. Because of the absence of mutational hotspots, Sanger sequencing is considered the gold standard for molecular analysis even if the workload is very laborious and expensive. To overcome this issue, different prescreening methods have been proposed, including DHPLC and biochemical studies on cultured dermal fibroblasts; however, both approaches present different drawbacks. Moreover, in case of patients who screen negative for point mutations, an additional screening step for complex rearrangements is required; the added causative variants expected from this approach are about 1–2%. The aim of this study was to optimize and validate a new protocol that combines quantitative PCR (qPCR) and high‐resolution melting (HRM) curve analysis to reduce time and costs for molecular diagnosis. Results of qPCR–HRM screening on 57 OI patients, validated by DHPLC–direct sequencing and multiplex ligation‐dependent probe amplification (MLPA), indicate that all alterations identified with the mentioned methodologies are successfully detected by qPCR–HRM. Moreover, HRM was able to discriminate complex genotypes and homozygous variants. Finally, qPCR–HRM outperformed direct sequencing and DHPLC–MLPA in terms of rapidity and costs. Hum Mutat 33:1697–1707, 2012.Keywords
This publication has 38 references indexed in Scilit:
- Genetic screening of Fabry patients with EcoTILLING and HRM technologyBMC Research Notes, 2011
- Exome Sequencing Identifies Truncating Mutations in Human SERPINF1 in Autosomal-Recessive Osteogenesis ImperfectaThe American Journal of Human Genetics, 2011
- Mutations in the Gene Encoding the RER Protein FKBP65 Cause Autosomal-Recessive Osteogenesis ImperfectaThe American Journal of Human Genetics, 2010
- Homozygosity for a Missense Mutation in SERPINH1, which Encodes the Collagen Chaperone Protein HSP47, Results in Severe Recessive Osteogenesis ImperfectaThe American Journal of Human Genetics, 2010
- Lack of Cyclophilin B in Osteogenesis Imperfecta with Normal Collagen FoldingNew England Journal of Medicine, 2010
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR ExperimentsClinical Chemistry, 2009
- CRTAPandLEPRE1mutations in recessive osteogenesis imperfectaHuman Mutation, 2008
- Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfectaNature Genetics, 2007
- Deficiency of Cartilage-Associated Protein in Recessive Lethal Osteogenesis ImperfectaNew England Journal of Medicine, 2006
- A Comparison of High-Resolution Melting Analysis With Denaturing High-Performance Liquid Chromatography for Mutation ScanningAmerican Journal of Clinical Pathology, 2005